STAT

DECEMBER 7, 2023

TIJUANA, Mexico — Just over a decade ago, when Crystal Pérez Lira needed an abortion, she had to leave Mexico. The procedure was illegal in her home state of Baja California and so deeply stigmatized that even Pérez Lira supported the procedure only for those who were raped. Until she unexpectedly got pregnant. She traveled to the U.S. for help, walking alone across the border from Tijuana to San Diego, first for a health check and a compulsory ultrasound, and then back for a se

362

362

PharmaVoice

DECEMBER 7, 2023

Shankar Narayanan, CEO of marketing consulting firm Real Chemistry, weighs in on where the industry is headed in the New Year.

174

174

STAT

DECEMBER 7, 2023

Imagine getting surgery without ever being cut open. Researchers at Duke University and Harvard Medical School have successfully demonstrated a proof of concept in new research published Thursday in Science using a 3D printer that uses ultrasound to print biomaterials inside an organ. Growing up, Junjie Yao, a bioengineer at Duke University and one of the primary investigators of the study, had heard stories about scientists coming up with great ideas over coffee or while chatting in the break r

Medical Schools 349

Medical Schools 349

The Pharmacist

DECEMBER 7, 2023

The Department of Health and Social Care (DHSC) has today launched its consultation into pharmacy supervision. It proposes to: enable pharmacists to authorise pharmacy technicians to carry out, or supervise others carrying out, the preparation, assembly, dispensing, sale and supply of medicines enable pharmacists to authorise any member of the pharmacy team to hand out […] The post Breaking: Pharmacy supervision consultation launches appeared first on The Pharmacist.

Pharmacy Technician 125

Pharmacy Technician 125

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

DECEMBER 7, 2023

The two leaders of the Senate Budget Committee on Thursday launched a bipartisan investigation into private equity ownership of hospitals in the United States, citing concerns that such arrangements are bad for both health care providers and patients. “As private equity has moved into health care, we have become increasingly concerned about the associated negative outcomes for patients,” said Chairman Sheldon Whitehouse (D-R.I.) in a statement.

Hospitals 341

Hospitals 341

BioPharma Dive

DECEMBER 7, 2023

The funding is indicative of investor interest in an area of drug research that involves at least a dozen startups and multiple publicly traded companies.

129

129

pharmaphorum

DECEMBER 7, 2023

AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist Cerevel Therapeutics which spun out of Pfizer in 2018.

112

112

STAT

DECEMBER 7, 2023

In 1997, Celgene obtained a key patent for what would become a blockbuster blood cancer treatment, giving it a monopoly until 2019. But like any pharmaceutical company with an eye toward the future, Celgene continued to seek other ways to wring profits from its development work. Not long after the patent was awarded, the company leveraged federally funded research and began investigating different forms of the compound, called Revlimid.

Drug Pricing 279

Drug Pricing Compounding Pharmaceutical Companies Pharmaceutical Companies 279

The Pharmacist

DECEMBER 7, 2023

The number of students accepted onto undergraduate pharmacy programmes across the UK has increased 3% in a year, according to latest data from the Universities and Colleges Admissions Service (UCAS). Community Pharmacy England (CPE) welcomed the rise and hoped the news ‘bodes well’ for recent commitments made by NHS England to expanding pharmacy training.

Community Pharmacies 106

Community Pharmacies 106

STAT

DECEMBER 7, 2023

Many families take for granted the ritual of taking a newborn baby home, car seat and curated swaddle blankets in tow, just a few days after delivery. But as critical care pediatricians, we care for babies and children who often don’t fit neatly into these universal experiences. When our patients go home for the first time, they are rarely newborns.

Hospitals 263

Hospitals 263

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

DECEMBER 7, 2023

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with David Solomon, CEO of Mithra Pharmaceuticals, about the current women’s health landscape and what Mithra is doing on an international scale to ameliorate that.

108

108

STAT

DECEMBER 7, 2023

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. March-in mania The White House today will take a long-awaited step to potentially broaden the government’s authority to undermine patents for medicines developed with taxpayer funding — including considering a drug’s price as one part of the framework, my co-aut

Diabetes 251

Diabetes 251

The Pharmacist

DECEMBER 7, 2023

The Royal Pharmaceutical Society (RPS) has been involved in conversations around a national vaccination strategy, its director for England has revealed. In an exclusive interview with The Pharmacist last month, RPS director for England James Davies said that the society had been calling for community pharmacists to be able to provide a ‘wraparound service’ to […] The post RPS involved in talks on national vaccination strategy appeared first on The Pharmacist.

Vaccines 95

Vaccines 95

STAT

DECEMBER 7, 2023

Will this be a half a loaf? After months of deliberation, the Biden administration on Thursday asserted its authority to sidestep patents in order to lower costs for some pricey medicines that were discovered with taxpayer money. But the move, which must still be finalized by an inter-agency working group, is already causing uncertainty over the extent to which drugmakers may lose valuable monopolies and consumers will save money.

246

246

European Pharmaceutical Review

DECEMBER 7, 2023

Results from a world-first human trial, published in the New England Journal of Medicine , has shown that a drug called baricitinib has promise as the first disease-modifying treatment of its kind for type 1 diabetes, that can be administered as a tablet.  baricitinib… [demonstrated an ability to] preserve the body’s own insulin production and suppress the progression of type 1 diabetes in people who initiated treatment within 100 days of diagnosis” The researchers noted that baricit

Diabetes 105

Diabetes Immunity Immunization 105

STAT

DECEMBER 7, 2023

White House officials will take more time to review a sweeping plan from U.S. health regulators to  ban menthol cigarettes , an unexpected delay that anti-tobacco groups fear could scuttle the  long-awaited rule. Administration officials indicated Wednesday the process will continue into next year, targeting March to implement the rule, according to an updated regulatory agenda posted online.

221

221

Pharma Times

DECEMBER 7, 2023

The disease is one of the leading causes of cancer deaths in the UK - News - PharmaTimes

137

137

STAT

DECEMBER 7, 2023

Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say, “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us.

Drug Pricing 201

Drug Pricing 201

PharmExec

DECEMBER 7, 2023

Arthritis, asthma, cancer, cardiovascular diseases, chronic kidney disease, COPD, depression, and diabetes reach the highest recorded levels since the America’s Health Rankings Annual Report began tracking them in 1990.

Diabetes 98

Diabetes 98

STAT

DECEMBER 7, 2023

How does the first CRISPR treatment work? Can biotech rebound? And when is $300 million not $300 million? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. With the first CRISPR-based medicine expected to win FDA approval any minute now, STAT’s Megan Molteni joins us to discuss how we got here and what it means for the future.

200

200

pharmaphorum

DECEMBER 7, 2023

Treatment with Eli Lilly’s JAK inhibitor Olumiant has been shown to preserve the function of insulin-producing pancreatic beta cells in patients with type 1 diabetes, potentially opening up a whole new avenue of therapy.

Diabetes 98

Diabetes 98

STAT

DECEMBER 7, 2023

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Good morning. Before we get to the serious news of the day, I’d like to take a page from my colleague Ed Silverman’s  playbook  and share some coffee news.

193

193

Express Pharma

DECEMBER 7, 2023

Following the FDA’s acceptance of Madrigal Pharmaceuticals ’ new drug application (NDA) and priority review for its THR-β agonist (resmetirom) in non-alcoholic steatohepatitis (NASH) in September 2023, the company has taken steps to fortify its leadership and financial position to gear up for the imminent launch of resmetirom. The measures initiated by Madrigal for the launch are expected to set the tone for future launches of NASH therapies by other small companies, according to GlobalData.

100

100

STAT

DECEMBER 7, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with another multibillion-dollar deal, a word on the future of Sanofi, and a setback in one of medicine’s longest-running quests.

Drug Pricing 190

Drug Pricing Drug Development Vaccines 190

Express Pharma

DECEMBER 7, 2023

The commission, in its alert, stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (PvPI) database revealed drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome The Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert advising healthcare professionals and patients to monitor adverse reactions of painkiller Meftal, commonly used for menstrual cramps and rheumatoid arthritis.

Adverse Reactions 100

Adverse Reactions 100

pharmaphorum

DECEMBER 7, 2023

Medtech giant Medtronic has decided not to go ahead with a planned acquisition of EOFlow, a developer of patch-based insulin pumps, saying that there have been “multiple breaches” of their takeover agreement.

93

93

Express Pharma

DECEMBER 7, 2023

India Pharma Inc, hailed for its prowess in the production of high-quality generic medicines, now needs to shift from a conventional, volume-based business strategy to a value-based approach to keep it up its growth momentum. In this context, finding the right opportunities and understanding the challenges has become crucial. Hence, Express Pharma is organising a series of “ Pharma Summits” across the country’s pharma hubs to strategically leverage opportunities as well as find and apply new ope

Generic Medicine 100

Generic Medicine Documentation 100

Pharmaceutical Technology

DECEMBER 7, 2023

Japan has granted approval for the sBLA of Bristol-Myers Squibb (BMS) for Abecma to treat relapsed or refractory multiple myeloma (RRMM).

105

105

Express Pharma

DECEMBER 7, 2023

The BioCompDiscoverX will be available in Q3 2024 and will include technologies incorporated in its proprietary silicon device Ceremorphic Life Sciences CEO Venkat Mattela delivered the keynote at AI Driven Drug Discovery Summit in Boston MA, where he demonstrated the company’s new BioCompDiscoverX supercomputing platform. Leveraging proprietary analog, quantum and AI technology, this new platform will allow Ceremorphic Life Sciences, a division of Ceremorphic, Inc., to begin developing drugs at

Medical Schools 93

Medical Schools Vaccines Drug Development 93

Outsourcing Pharma

DECEMBER 7, 2023

Virtual research organization, ObvioHealth, has just announced the launch of its application programming interface (API) which it says is tailored specifically for digital therapeutics (DTx) clinical trials.

89

89

World Pharma News

DECEMBER 7, 2023

Salus Optima, a leading provider in AI-enabled digital health and wellness solutions, and the Consumer Health division of Bayer have launched a strategic partnership to empower people on their healthy aging journey. The partnership elevates the shared aspiration of both companies to transform self-care by offering precision health solutions to enable consumers to better understand and make informed decisions about their own personal health and lifestyle choices.

86

86

The Script

DECEMBER 7, 2023

Poor work habits can significantly hinder productivity and professional growth. Rx relief shares five common habits and how to overcome them.

98

98

pharmaphorum

DECEMBER 7, 2023

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of the decade, a sharp increase on earlier predictions.

86

86

European Pharmaceutical Review

DECEMBER 7, 2023

A report from the Advanced Therapies Treatment Centre (ATTC) Network has highlighted urgent need for rapid change and improvement in the field to maximise patient access to advanced therapies. It was compiled based on expertise gathered at the ATTC Network’s UK Advanced Therapies Adoption Challenge event in October. At the event, attendees discussed barriers and develop solutions to the advanced therapies adoption challenge.

85

85

Express Pharma

DECEMBER 7, 2023

India’s pharma market is rapidly gaining momentum and witnessing significant growth globally. However, in this promising landscape, it is imperative for the industry to embrace a paradigm shift from a conventional, volume-based business strategy to a value-driven approach. Therefore, the overarching theme for this year’s Pharma Summits organised by Express Pharma is “ Volume to Value Leadership: Opportunities and Challenges for India Pharma Inc.” After the resounding succ

Packaging 85

Packaging Biosimilars 85